Pfizer, Inc.: dividend
Price
$28.89
November 13, 2026Market cap $164B
What Ploutos Investor adds for Pfizer
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Yield
5.95%
$1.72 per share over the last 12 months, at a price of $28.89.
- FCF coverThe year's free cash flow was 1.2 times the dividend it paid.
- 1.2x
- Payout246% of the last 12 months' earnings went to the dividend.
- 246%
- No cutWithout a cut since 2009, the first year of our figures: the run may be longer.
- 16+
- 5-year growthAverage yearly growth over the last five years.
- +2.4%
- Debt / EBITDAMoney that goes to interest does not go to the dividend.
- 4.8x
The dividend year by year
What it paid per share each fiscal year, how much that changed, and the yield it gave at the price at year end.
- 2025Dividend per share$1.72
- 2024Dividend per share$1.69
- 2023Dividend per share$1.65
| Year | Dividend per share | Change | Price | Yield then | As % of earnings |
|---|---|---|---|---|---|
| 2025 | $1.72 | +1.8% | $24.90 | 6.91% | 126% |
| 2024 | $1.69 | +2.4% | $26.53 | 6.37% | 120% |
| 2023 | $1.65 | – | $28.79 | 5.73% | > 300% |
Each fiscal year's dividend as the company states it in its filings, adjusted for stock splits. Special dividends count in the year they were paid.
The dividend year by year
PFE's dividend per share each fiscal year, from 2009 to 2022, 14 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Everything it returns to shareholders
The dividend is one way. The other is buybacks, which reduce the number of shares.
Dividend yield
5.95%
$59.50 a year per $1,000 of shares
Buybacks
–
The share count rose by 0.3% over the year, so more shares were issued than bought back.
Total returned
5.95%
$59.50 a year per $1,000 of shares
PFE beside the other dividend payers
Where it stands among this week's 968 dividend payers, and in the Healthcare sector. The dot is the company, the white line the median.
Above 95% of the payers · median 2.03%
In Healthcare: above 96%, median 0.93%.
Above 12% of the payers · median 3.6x
In Healthcare: above 4%, median 4.4x.
Above 23% of the payers · median +6.3%
In Healthcare: above 21%, median +5.8%.
Among the highest on the list · median 35%
In Healthcare: above 96%, median 25%.
The full analysis
What do Pfizer's filings show?
The dividend is one part of Pfizer's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is PFE's dividend yield?
Pfizer paid $1.72 per share over the last 12 months. At a price of $28.89, that is a yield of 5.95%.
Does PFE cover its dividend with the cash it makes?
Yes, over the last year. Pfizer's free cash flow was 1.2 times the dividend it paid.
Has PFE ever cut its dividend?
Pfizer has not cut its dividend for 16+ years, in the 17 years of figures we hold.
How much has PFE's dividend grown?
Pfizer's dividend per share changed by +2.4% a year on average over the last five years.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.